Needham Maintains Buy on Alkermes, Raises Price Target to $54

Benzinga Newsdesk www.benzinga.com Positive 68.6%

Neg 0% Neu 0% Pos 68.6%

Needham analyst Ami Fadia maintains Alkermes (NASDAQ:ALKS) with a Buy and raises the price target from $50 to $54.

Comments

No comments yet. Be the first!